Neusoft Medical's groundbreaking NeuViz P10 photon-counting CT has secured official approval for market launch from the National Medical Products Administration (NMPA). As the first of its kind in China and globally, featuring an 8cm wide-body design, this innovation signifies a pivotal shift from a follower to a leader in next-generation CT technology. The NeuViz P10 employs cadmium zinc telluride (CZT) photon-counting detectors, redefining traditional CT imaging principles to deliver ultra-high definition, ultra-low dose, and multi-energy imaging capabilities. Leveraging "photon direct reading," this technology achieves an impressive 50 lp/cm ultra-high resolution while substantially reducing radiation exposure. Integrating 17 advanced AI technologies, it comprehensively elevates the accuracy, safety, speed, and intelligence of CT operations. Neusoft Medical has forged partnerships with numerous leading tertiary hospitals to explore the extensive application potential of this technology in complex disease scenarios.